| Literature DB >> 33891876 |
Mathieu Bourdenx1, Adrián Martín-Segura2, Aurora Scrivo2, Jose A Rodriguez-Navarro2, Susmita Kaushik2, Inmaculada Tasset2, Antonio Diaz2, Nadia J Storm2, Qisheng Xin3, Yves R Juste2, Erica Stevenson4, Enrique Luengo5, Cristina C Clement6, Se Joon Choi7, Nevan J Krogan4, Eugene V Mosharov7, Laura Santambrogio6, Fiona Grueninger8, Ludovic Collin8, Danielle L Swaney4, David Sulzer9, Evripidis Gavathiotis10, Ana Maria Cuervo11.
Abstract
Components of the proteostasis network malfunction in aging, and reduced protein quality control in neurons has been proposed to promote neurodegeneration. Here, we investigate the role of chaperone-mediated autophagy (CMA), a selective autophagy shown to degrade neurodegeneration-related proteins, in neuronal proteostasis. Using mouse models with systemic and neuronal-specific CMA blockage, we demonstrate that loss of neuronal CMA leads to altered neuronal function, selective changes in the neuronal metastable proteome, and proteotoxicity, all reminiscent of brain aging. Imposing CMA loss on a mouse model of Alzheimer's disease (AD) has synergistic negative effects on the proteome at risk of aggregation, thus increasing neuronal disease vulnerability and accelerating disease progression. Conversely, chemical enhancement of CMA ameliorates pathology in two different AD experimental mouse models. We conclude that functional CMA is essential for neuronal proteostasis through the maintenance of a subset of the proteome with a higher risk of misfolding than the general proteome.Entities:
Keywords: Alzheimer’s disease; aging; chaperones; chemical activators of autophagy; lysosomes; neurodegeneration; protein aggregation; proteotoxicity; supersaturated proteome; tau
Mesh:
Substances:
Year: 2021 PMID: 33891876 PMCID: PMC8152331 DOI: 10.1016/j.cell.2021.03.048
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 66.850